Beta Bionics, Inc. (BBNX) Cost of Revenue (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Cost of Revenue data on file, last reported at $20.7 million in Q1 2026.

• Quarterly Cost of Revenue rose 139.21% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.7 million (up 71.12% YoY) and the FY2025 annual result came in at $44.7 million, up 52.94% from the prior year.
• Cost of Revenue grew to $20.7 million in Q1 2026 per BBNX's latest filing, from $13.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $20.7 million in Q1 2026, with the low at $5.7 million in Q1 2024.
• Average Cost of Revenue over 3 years is $11.5 million, with a median of $9.6 million recorded in 2024.
• Year-over-year, Cost of Revenue increased 25.81% in 2025 and jumped 139.21% in 2026.
• Beta Bionics' Cost of Revenue stood at $8.8 million in 2024, then surged by 50.58% to $13.2 million in 2025, then jumped by 57.36% to $20.7 million in 2026.
• Business Quant data shows BBNX's Cost of Revenue at $20.7 million in Q1 2026, $13.2 million in Q4 2025, and $12.1 million in Q3 2025.